title: Long-term treatment with fumaric acid esters in an 11-year-old male child with psoriasis.
abstract: Moderate to severe psoriasis is common in childhood and adolescence and is often a challenge for the treating dermatologist. In most cases, systemic therapies in children are only available 'off-label'. Fumaric acid esters (FAEs) have been used successfully in the treatment of moderate to severe psoriasis in adults and are recommended for long-term treatment in the German S3 guideline. In childhood psoriasis, FAEs may be a treatment alternative if a systemic therapy is indicated. Here, we report about the successful long-term treatment with FAEs in a male child with severe psoriasis.
authors.affiliation: Psoriasis Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany. sgerdes@dermatology.uni-kiel.de
authors.forename: S
authors.initials: S
authors.lastname: Gerdes
authors.forename: S
authors.initials: S
authors.lastname: Domm
authors.forename: U
authors.initials: U
authors.lastname: Mrowietz
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D002648:Child; D004359:Drug Therapy, Combination; D005650:Fumarates / Q000627:therapeutic use*; D006801:Humans; D008134:Long-Term Care; D018655:Lymphocyte Count; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*; D012720:Severity of Illness Index; D014807:Vitamin D / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D005650:Fumarates; D014807:Vitamin D